Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin
Joint Authors
Chiang, Tom
Gomez, Eric
Lao, Dominador
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-07-09
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
The occurrence of Clostridium difficile colitis is on the rise and has become more difficult to manage with standard therapy.
Thus, the need for alternative treatments is essential.
Tigecycline is a glycylcycline antibiotic that has been shown to be effective against C.
difficile through several published case reports and in in vitro studies.
We present a case of C.
difficile colitis that failed to respond to metronidazole and oral vancomycin therapy, but improved on a combination of rifaximin, tigecycline, and vancomycin.
American Psychological Association (APA)
Lao, Dominador& Chiang, Tom& Gomez, Eric. 2012. Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin. Case Reports in Medicine،Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-491772
Modern Language Association (MLA)
Lao, Dominador…[et al.]. Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin. Case Reports in Medicine No. 2012 (2012), pp.1-3.
https://search.emarefa.net/detail/BIM-491772
American Medical Association (AMA)
Lao, Dominador& Chiang, Tom& Gomez, Eric. Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin. Case Reports in Medicine. 2012. Vol. 2012, no. 2012, pp.1-3.
https://search.emarefa.net/detail/BIM-491772
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-491772